Keywords: richter, gedeon, nine-month, profit, grows, hungarian, drugmaker
Richter Gedeon's nine-month profit grows 7%
Article | 22 November 2004
Hungarian drugmaker Richter Gedeon saw its profit for the nine months to September 30, 2004, climb 7% (16.8% in US dollar terms) to 26.3 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
